Syros Pharmaceuticals Inc (SYRS) stock has risen 27.14% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives SYRS stock a score of 74 out of a possible 100.
That rank is chiefly influenced by a long-term technical score of 95. SYRS's rank also includes a short-term technical score of 89. The fundamental score for SYRS is 38. In addition to the average rating from Wall Street analysts, SYRS stock has a mean target price of 12.166. This means analysts expect the stock to add 36.70% over the next 12 months.
What's Happening with SYRS Stock Today
Syros Pharmaceuticals Inc (SYRS) stock is up 0.56% while the S&P 500 has risen 0.98% as of 11:31 AM on Tuesday, May 5. SYRS has risen $0.05 from the previous closing price of $8.85 on volume of 152,026 shares. Over the past year the S&P 500 has fallen -2.11% while SYRS has risen 27.14%. SYRS lost -$1.88 per share in the over the last 12 months.